AKT cascade in intrahepatic cholangiocarcinoma

Overview of attention for article published in Cell Death & Disease, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 1,956 followers.

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma ... https://t.co/b5IXfc5oSS

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma https://t.co/b5IXfbNNui

Using in vitro experiments, investigators at @FudanUniv Liver Cancer Institute found that #anlotinib had significant effects on proliferation inhibition, migration, and cell-cycle arrest in intrahepatic #cholangiocarcinoma. 📔@cddpress: https://t.co/VsMIE3